Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent pharmacies, allowing
Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary
Categories
Health Care
Patterson Companies, Inc. (PDCO) Q1 2023 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ: PDCO) Q1 2023 earnings call dated Sep. 01, 2022 Corporate Participants: John Wright -- Vice President of Investor Relations Mark
IPO Alert: Third Harmonic files to go public. Here’s what you need to know
IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but it is
Medtronic PLC (MDT) Q1 2023 Earnings Call Transcript
Medtronic PLC (NYSE: MDT) Q1 2023 earnings call dated Aug. 23, 2022 Corporate Participants: Ryan Weispfenning -- Vice President and Head of Investor Relations
Jaguar Health, Inc. (JAGX) Q2 2022 Earnings Call Transcript
Jaguar Health, Inc. (NASDAQ: JAGX) Q2 2022 earnings call dated Aug. 22, 2022 Corporate Participants: Lisa Conte -- Founder & Chief Executive Officer Carol
Bio Path Holdings Inc. (BPTH) Q2 2022 Earnings Call Transcript
Bio Path Holdings Inc. (NASDAQ: BPTH) Q2 2022 earnings call dated Aug. 16, 2022 Corporate Participants: WIll O'Connor -- Managing Director Peter Nielsen -- President and
Agilent Technologies Inc. (A) Q3 2022 Earnings Call Transcript
Agilent Technologies Inc. (NYSE: A) Q3 2022 earnings call dated Aug. 16, 2022 Corporate Participants: Parmeet Ahuja -- Vice President of Investor
Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term
Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a mixed sentiment
Cipher Pharmaceuticals Inc. (CPH) Q2 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. ( TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott
Cipher Pharmaceuticals Inc. (CPH) Q2 2022 Earnings Call Transcript
Cipher Pharmaceuticals Inc. (TSE: CPH) Q2 2022 earnings call dated Aug. 12, 2022 Corporate Participants: Craig Mull -- Interim Chief Executive Officer Scott Langille -- Chief
Cardinal Health Inc. (CAH) Q4 2022 Earnings Call Transcript
Cardinal Health Inc. (NYSE: CAH) Q4 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Kevin Moran -- Vice President of Investor Relations Mike
Illumina, Inc. (ILMN) Q2 2022 Earnings Call Transcript
Illumina, Inc. (NASDAQ: ILMN) Q2 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Salli Schwartz -- Vice President of Investor Relations Francis deSouza -- Chief
Veru Inc. (VERU) Q3 2022 Earnings Call Transcript
Veru Inc. (NASDAQ: VERU) Q3 2022 earnings call dated Aug. 11, 2022 Corporate Participants: Samuel Fisch -- Executive Director, Investor Relations & Corporate Communications
CATALYST PHARMACEUTICALS INC (CPRX) Q2 2022 Earnings Call Transcript
CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q2 2022 earnings call dated Aug. 10, 2022 Corporate Participants: Alicia Grande -- Chief Financial Officer Patrick J. McEnany -- Co-Founder, Chairman,
BioLife Solutions Inc. (BLFS) Q2 2022 Earnings Call Transcript
BioLife Solutions Inc. (NASDAQ: BLFS) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
Perrigo Co PLC (PRGO) Q2 2022 Earnings Call Transcript
Perrigo Co PLC (NYSE: PRGO) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations and
PetIQ, Inc. (PETQ) Q2 2022 Earnings Call Transcript
PetIQ, Inc. (NASDAQ: PETQ) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
10X Genomics Inc. (TXG) Q2 2022 Earnings Call Transcript
10X Genomics Inc. (NASDAQ: TXG) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Cassie Corneau -- Investor Relations Serge Saxonov -- Chief Executive Officer,
Cara Therapeutics , Inc. (CARA) Q2 2022 Earnings Call Transcript
Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer and Head
ANI Pharmaceuticals, Inc. (ANIP) Q2 2022 Earnings Call Transcript
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Lisa M. Wilson -- Investor Relations Nikhil Lalwani -- President and